Randomized Study Comparing a Novel Intranasal Formulation of Bumetanide With Oral and Intravenous Formulations

Affiliations

• ¹ Kaiser Permanente San Francisco Medical Center, CA (A.P.A.).
• ² Kaiser Permanente Northern California Division of Research, Pleasanton (A.P.A.).
• ³ Cone Health, Greensboro, NC (D.B.).
• ⁴ Ventricle Health, Greensboro, NC (D.B.).
• ⁵ Azure Delta Consulting, Thornhill, Ontario, Canada (G.B.).
• ⁶ Providence St Joseph Medical Center, Orange, CA (B.K.).
• ⁷ Orange County Research Center, Lake Forest, CA (J.N.).
• ⁸ Mount Sinai Fuster Heart Hospital, New York, NY (A.L.).
• ⁹ Icahn School of Medicine at Mount Sinai, Division of Population Health, New York, NY (A.L.).
• ¹⁰ Tufts Medical Center, The Cardiovascular Center for Research and Innovation, Boston, MA (N.K.K.).
• ¹¹ Tufts University School of Medicine, Boston, MA (N.K.K.).
• ¹² Corstasis Therapeutics Inc, Henderson, NV (B.E.).
• ¹³ University of California, San Diego Medical Center (E.A.).